Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease
In a recent paper by Béné and Kaeda, 1 technical approaches for minimal residual disease (MRD) assessment are extensively reviewed. PCR-based studies have proved to be 1-log more sensitive than flow cytometry (FC). For this reason, they are increasingly being considered preferable for MRD analysis, especially at the end of therapy or posthematopoietic stem cell transplantation. 1, 2 It would be valuable to develop MRD flow cytometry assays with this level of sensitivity that could be applied routinely. In the present work, we analysed MRD + samples with a level of infiltration below the limit of detection of routine FC, which is accepted as 10 -4 and comes from the standard acquisition of 2!5 " 10 5 leukocytes. [3] [4] [5] [6] [7] [8] [9] [10] [11] At least 10 fold more leukocytes must be acquired to increase sensitivity by one log; this large number of leukocytes can be acquired easily in digital cytometers by acquiring several individual tubes stained with the same combination of monoclonal antibodies, and appending them in a single file. Because the time of acquisition for each individual tube is not increased, no problems of cellular aggregation arise. Using this approach, we acquired 6 million leukocytes from each sample using a FACSCanto flow cytometer (Becton-Dickinson). The stability of fluorescent parameters between tubes was verified (Online Supplementary Figure S1 ). The study was performed with the event rate used routinely in our laboratory, i.e. 2000 events/sec. To explore the possibility of decreasing acquisition time, we analyzed the influence of increasing the event rate on the percentage of electronic aborts (due mainly to coincidence events), and compared MRD measurements in samples acquired at different event rates (Online Supplementary Table S1 ). We found that the acquisition event rate could be increased reliably to at least 4000 events/sec. Using this event rate, the time of acquisition of 6 million leukocytes is suitable for routine measurements.
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We assessed that this approach enhanced sensitivity by 1 log by comparing MRD analysis by FC with real-time quantitative PCR for BCR-ABL1 p190 transcripts in serial dilutions of a Philadelphia cromosome-positive B-II acute lymphoblastic leukemia sample (Table 1A) .
Thereafter we selected multiple myeloma (MM) and B-cell chronic lymphocytic leukemia (B-CLL) MRD+ samples with about 0.01% infiltration and diluted them 10-fold with normal leukocytes. As shown in Table 1B , MRD was detected accurately in all diluted samples (10 -5 infiltration). Observed values were within the expected ±10% in all cases.
This increase in sensitivity did not compromise the specificity of the technique. Ten million leukocytes from the bone marrow of patients (n = 3) without hematological neoplasias and from the peripheral blood of healthy donors (n = 3) were acquired and blindly tested for the presence of events with a myelomatous or B-CLL phenotype, respectively. The results were unambiguously negative (Online Supplementary Figure S2 ). We also acquired 10 million normal leukocytes and searched for events with phenotypic characteristics of other hematological malignancies, such as follicular lymphoma and hairy cell leukemia, with negative results.
In addition to the total number of leukocytes analysed, the sensitivity of FC depends on the number of neoplastic events that must be detected in order to obtain precise measurements.
Based on the theory that rare events follow a Poisson distribution, it is accepted that 50-100 events are needed to reliably measure the frequency of a population. 3, 7, 8, 11, 12 However, to our knowledge, no studies have really measured the influence of the number of detected tumoral cells on MRD measurement precision. Accordingly, we determined the coefficient of Increasing event rates were achieved by increasing the concentration of leukocytes in the acquisition tubes. Results are the mean of three independent trials. Based on these results, we considered that 4000 events/sec could be a reasonable flow rate for routine analysis.
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